Join us at CEoT 2026, a three-day meeting focused on advancing transplantation science, clinical practice, and patient outcomes. This meeting will explore the future of transplantation across all organ types, highlighting innovation, equity, and lifelong patient care. Hear from leading experts and engage in interactive breakout sessions across specialties, focusing on emerging technologies, allocation strategies, and the changing landscape of organ disease.

The 2026-2027 Board of Directors nomination window is now open! The AST is currently accepting nominations for President, Treasurer, and three Councilors-at-Large. The election will begin in April 2026, and newly elected board members will begin their terms on June 22, 2026, following the AST Town Hall at the American Transplant Congress.

As the 2025 AST membership year begins to close, don't forget to renew your membership and reaffirm your commitment to the AST. Renewal invoices were distributed via email and are due December 31, 2025. If you didn't receive your email, you may log in anytime to your AST member account. Don't miss out on all future AST educational, networking, advocacy, and research efforts!

The Donation Derby is back — and your Community of Practice (COP) needs your support! Every gift you make helps fund your COP’s initiatives and projects and brings them one step closer to victory. Rally behind your COP, make a donation, and help them race to the top!

The AST is now accepting applications for its 2026 Career Development Grant cycle! These grants promote the careers of early-career investigators whose research relates to solid organ transplantation (and/or immunology relating to solid organ transplant).

Source: American Board of Internal Medicine
Applicants from all backgrounds are encouraged to apply. Because ABIM strives to have representation from a cross-section of the profession bringing a broad range of perspectives, ABIM particularly welcomes applications from those with experience in rural medicine, leaders in academic medicine and physicians who are clinically active. Individual candidates are not expected to hold all of these qualities; applicants who bring strength in any area are encouraged to apply. 

The AST developed a survey aimed at soliciting your perspectives on legislative and regulatory issues that significantly influence both patient care and professional practice. Our goal is to establish a platform for our membership to share their invaluable ideas and perspectives and actively engage with the Public Policy Committee and AST leadership. We look forward to your input as we navigate the dynamics of our ever-evolving landscape of transplant care and practice.

Source: Wiley Online Library
Simultaneous pancreas and kidney (SPK) transplants using steroid-free regimens are a frequently used immunosuppressive strategy in low immunologic risk recipients. The long-term effect on recipient outcomes remains incompletely understood.

Source: Wiley Online Library
A total of 46 721 donor-recipient matches were identified. PHM demonstrated higher survival for properly sized and oversized patients compared to undersized (p < 0.01). For IPHM, survival was highest in the properly sized patients, lower in the oversized, and lowest in the undersized patients (p < 0.01). For IBW, survival was superior in properly sized group compared to undersized and oversized patients (p < 0.03). Non-linear analysis of PHM showed increased mortality risk with undersizing and decreased risk with oversizing (p < 0.01). IPHM demonstrated higher mortality risk with undersizing but no notable risk with oversizing (p < 0.01), whereas IBW showed increased risk with both undersizing and oversizing (p < 0.01).

Source: Thoracic Surgery Clinics
The field of lung transplantation has had significant advancements in recent years allowing us to help more patients who have end-stage lung failure.

Source: LWW Journals
Geographic variation in liver transplant access in the United States have spurred interest in spatial accessibility to care. There is currently no consensus about which measure should be used for spatial accessibility. We used 2015–2022 data from the Scientific Registry of Transplant Recipients and the National Center for Health Statistics to calculate county listing-to-death ratios (LDR) for liver transplant. We used a two-step floating catchment area approach to define a novel measure of spatial accessibility (Spatial Accessibility Ratio, SPAR). We compared this measure to other accessibility measures using generalized linear models and Vuong’s non-nested hypothesis test. Across 3,108 included counties, SPAR ranged from 0.56 to 9.98; 29% of counties and 65% of the population had a SPAR≥1 (mean or better accessibility to liver transplant). SPAR outperformed distance (p<0.001), rurality (p<0.001), and health care resource-based measures (p<0.001) in predicting population-based transplant access; SPAR remained significantly associated with LDR after adjustment for other county-level factors.